Juvenile myelomonocytic leukemia: Analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG)

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1111-1116

  Lutz, P ^a,l   Zix Kieffer, I ^a   Souillet, G ^a   Bertrand, Y ^a   Dhooge, C ^b   Rubie, H ^c   Mazingue, F ^d   Marguerite, F ^e   Mechinaud Lacroix, F ^f   Rialland, X ^g   Plouvier, E ^h   Behar, C ⁱ   Vilmer, E ^j   Philippe, N ^a   Otten, J ^k  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b Serv d'Hematologie de l'Enfant   (France)

^c Serv d'Hematologie de l'Enfant   (France)

^d Serv d'Hematologie de l'Enfant   (France)

^e Service d'Hématologie Biologique   (France)

^f Serv d'Hematologie de l'Enfant   (France)

^g Service d'Hematologie   (France)

^h Service d'Hématologie   (France)

ⁱ HÔPITAL ROBERT DEBRÉ   (France)

^j Serv d'Hematologie de l'Enfant   (Belgium)

^k Service d'hématologie HÔpital Erasme   (Belgium)

^l UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

Juvenile myelomonocytic leukemia; Marrow transplantation; Mortality; Treatment

Indexed keywords

BUSULFAN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HYDROXYUREA; INTERFERON; ISOTRETINOIN; MELPHALAN; MERCAPTOPURINE;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; INFECTIOUS COMPLICATION; MALE; MYELOMONOCYTIC LEUKEMIA; NEURILEMOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPLENECTOMY; SURVIVAL TIME;

6-MERCAPTOPURINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL RESPONSE MODIFIERS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTARABINE; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; INFANT; INTERFERONS; ISOTRETINOIN; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LIFE TABLES; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SPLENECTOMY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 12644291916     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chan HS, Estrov Z, Weitzman SS, Freedman MH. The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 1987: 5: 1960-1967.
2. Niemeyer C, Arico M, Biondi A et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 104 patients. Blood 1994; 84 (Suppl. 1): 78a Abstr.
3. Castro-Malaspina H, Schaison G, Passe et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML): clinical and hematologic observations, and identification of prognostic factors. Cancer 1984; 54: 675-686.
4. Owen G, Lewis IJ, Morgan M et al. Prognostic factors in juvenile chronic granulocytic leukaemia. Br J Cancer 1992; 66 (Suppl. XVIII): 68-71.
5. Veys P, Saunders F, Calderwood S et al. The role of graft-versus-leukemia in bone marrow transplantation for juvenile chronic myeloid leudaemia. Blood 1994; 84 (Suppl. 1): 337a Abstr.
6. Maybee D, Dubowy R, Krischer et al. Unusual toxicity of high dose alpha interferon in the treatment of juvenile chronic myelogenous leukemia. Proc Am Soc Clin Oncol 1992; 11: 950.
7. Castleberry P., Emanuel D, Zuckerman S et al. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. New Engl J Med 1994; 22: 1680-1684.
8. Festa RS, Shende A, Lanzkowsky P. Juvenile chronic myelogenous leukemia: experience with intensive conbination chemotherapy. Med Ped Oncol 1990; 18: 311-316.
9. Emanuel PD, Bates LJ, Zhu SW et al. GM-CSF dysregulation in juvenile chronic myelogenous leukemia. Blood 1990; 76 (Suppl. 1): Abstr. 1058.
10. Weinstein HJ, Mayer RJ, Rosenthal DS et al. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 1983; 62: 315-319.
11. Creutzig V, Ritter J, Riehm H et al. Improved treatment results in childhood acute myelogenous leukemia: a report of the German Cooperative Study AML-BFM 78. Blood 1985; 65: 298-304.
12. Behar C, Suciu S, Benoit Y et al. Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC children leukemia cooperative study 58872 Med Ped Oncol 1996; 26: 173-179.
13. Wolff SN, Herzig RH, Fay JW et al. High dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long term follow up and results. J Clin Oncol 1989; 7: 1260-1267.
14. Arico M, Bossi G, Schiro R et al. Juvenile chronic myelogenous leukemia: report of the italian registry. Haematologica 1993; 78: 264-269.
15. Lilleyman JS, Harrison JF, Black JA. Treatment of juvenile chronic myelogenous leukemia with sequential subcutanous cytarabine and oral mercaptopurine. Blood 1977; 49: 559-562.
16. Sanders JE, Buckner CD, Thomas ED et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988; 71: 1144-1146.
17. Smith FO, Sanders JE, Robertson KA et al. Allogeneic marrow transplantation (BMT) for children with juvenile chronic myelogenous leukemia (JCML). Blood 1994; 84 (Suppl. 1): 201a Abstr.
18. Donadieu J, Stephan JL, Blanche S et al. Treatment of jevenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 777-782.
19. Pamphilon DH, Cornish JM, Goodman S et al. Successful second unrelated donor BMT in a child with juvenile chronic leukemia: documentation of chimaerism using the polymerase chain reaction. Bone Marrow Transplant 1993; 11: 81-84.
20. Rassam SM, Katz F, Chessells JM, Morgan G. Successful allogeneic bone marrow transplantation in juvenile CML: conditioning or graft-versus leukemia effect. Bone Marrow Transplant 1993; 11: 247-250.
21. Urban C, Schwinger W, Slave I et al. Busulfan/ cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia. Bone Marrow Transplant 1990; 5: 353-356.
22. Pession A, Locatelli F, Bonetti F et al. Role of allogeneic BMT from HLA identical sibling or matched unrelated donor in the treatment of children with juvenile chronic myeloid leukemia (JCML). Bone Marrow Transplant 1995; 15 (Suppl. 2): S18 Abstr.
23. Bunin NJ, Casper JT, Lawton C et al. Allogeneic marrow transplantation using T-cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bone Marrow Transplant 1992; 9: 119-122.